NOD1 and NOD2, as sensors of microorganisms and cellular stress, have been identified as potential therapeutic targets in a range of autoimmune and autoinflammatory disorders (52) and in diabetes, asthma, atherosclerosis, various forms of CNS diseases and even cancer (29). The gene discussed is NOD1; the disease is cancer.